X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15889) 15889
Publication (911) 911
Book Review (130) 130
Book Chapter (108) 108
Conference Proceeding (58) 58
Newsletter (45) 45
Magazine Article (36) 36
Dissertation (12) 12
Book / eBook (6) 6
Web Resource (4) 4
Reference (3) 3
Journal / eJournal (2) 2
Newspaper Article (2) 2
Trade Publication Article (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11219) 11219
male (5620) 5620
female (5422) 5422
middle aged (4506) 4506
adult (4242) 4242
index medicus (3267) 3267
vasculitis (3222) 3222
aged (2758) 2758
wegener's granulomatosis (2671) 2671
granulomatosis with polyangiitis - diagnosis (2585) 2585
wegeners-granulomatosis (2551) 2551
rheumatology (2418) 2418
granulomatosis with polyangiitis - complications (2236) 2236
diagnosis, differential (1972) 1972
granulomatosis (1663) 1663
granulomatosis with polyangiitis - drug therapy (1648) 1648
granulomatosis with polyangiitis - pathology (1627) 1627
medicine, general & internal (1497) 1497
systemic vasculitis (1439) 1439
granulomatosis with polyangiitis - immunology (1289) 1289
granulomatosis with polyangiitis (1242) 1242
wegeners granulomatosis (1212) 1212
adolescent (1191) 1191
diagnosis (1188) 1188
disease (1156) 1156
immunosuppressive agents - therapeutic use (1155) 1155
anca (1150) 1150
antineutrophil cytoplasmic antibodies (1116) 1116
autoantibodies (1098) 1098
microscopic polyangiitis (1055) 1055
biopsy (1044) 1044
immunology (962) 962
treatment outcome (950) 950
cyclophosphamide - therapeutic use (939) 939
urology & nephrology (894) 894
cyclophosphamide (868) 868
churg-strauss-syndrome (840) 840
antibodies, antineutrophil cytoplasmic - blood (820) 820
anca-associated vasculitis (786) 786
retrospective studies (781) 781
glomerulonephritis (768) 768
rituximab (765) 765
tomography, x-ray computed (762) 762
vasculitis - immunology (759) 759
wegener granulomatosis (751) 751
child (705) 705
classification (692) 692
pathology (686) 686
therapy (675) 675
prognosis (646) 646
aged, 80 and over (629) 629
antibodies (629) 629
antibodies, antineutrophil cytoplasmic - immunology (624) 624
medicine & public health (576) 576
antibodies, antineutrophil cytoplasmic (572) 572
respiratory system (568) 568
polyarteritis-nodosa (557) 557
recurrence (557) 557
vasculitis - diagnosis (554) 554
rheumatoid-arthritis (553) 553
follow-up studies (551) 551
animals (533) 533
lung - pathology (531) 531
care and treatment (526) 526
drug therapy, combination (522) 522
granulomatosis with polyangiitis - therapy (522) 522
granulomatosis with polyangiitis - diagnostic imaging (514) 514
risk factors (513) 513
abridged index medicus (511) 511
churg-strauss syndrome (509) 509
magnetic resonance imaging (492) 492
radiography (472) 472
neutrophils - immunology (450) 450
antibody-associated vasculitis (445) 445
neutrophils (445) 445
young adult (443) 443
involvement (422) 422
lymphomatoid granulomatosis (422) 422
enzyme-linked immunosorbent assay (414) 414
inflammation (412) 412
glucocorticoids - therapeutic use (410) 410
myeloperoxidase (407) 407
sarcoidosis (405) 405
manifestations (399) 399
prednisone - therapeutic use (398) 398
systemic-lupus-erythematosus (395) 395
lymphomatoid granulomatosis - pathology (393) 393
vasculitis - pathology (389) 389
surgery (387) 387
peroxidase - immunology (386) 386
otorhinolaryngology (384) 384
patients (384) 384
ophthalmology (376) 376
autoantibodies - analysis (373) 373
disease-activity (373) 373
antineutrophil cytoplasmic autoantibodies (369) 369
myeloblastin (369) 369
research (363) 363
remission induction (357) 357
rheumatology 1990 criteria (356) 356
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12597) 12597
French (933) 933
German (873) 873
Spanish (428) 428
Japanese (335) 335
Russian (220) 220
Polish (161) 161
Italian (95) 95
Korean (86) 86
Portuguese (71) 71
Chinese (53) 53
Czech (53) 53
Dutch (33) 33
Turkish (30) 30
Danish (21) 21
Hungarian (19) 19
Croatian (14) 14
Finnish (14) 14
Romanian (14) 14
Swedish (14) 14
Norwegian (11) 11
Slovak (7) 7
Hebrew (6) 6
Serbian (4) 4
Ukrainian (3) 3
Bulgarian (2) 2
Persian (2) 2
Arabic (1) 1
Greek (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, 1st Edition., ISBN 9781849962469, xxii, 193
Systemic vasculitides are an increasingly important group of disorders, many of which present significant diagnostic challenges. Including full-color... 
diagnosis | therapy | Vasculitis | Clinical & internal medicine | Vasculitis - therapy
Book
Rheumatology, ISSN 1462-0324, 07/2018, Volume 57, Issue 7, pp. 1307 - 1309
Journal Article
Rheumatology, ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
European Journal of Pediatric Dermatology, ISSN 1122-7672, 2018, Volume 28, Issue 3, p. 192
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2017, Volume 12, Issue 10, pp. e0185880 - e0185880
Objectives The treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is based on remission-induction and remission-maintenance.... 
WEGENERS-GRANULOMATOSIS | CHURG-STRAUSS-SYNDROME | ANTIBODY-ASSOCIATED VASCULITIS | EOSINOPHILIC GRANULOMATOSIS | RENAL VASCULITIS | RITUXIMAB | MULTIDISCIPLINARY SCIENCES | AZATHIOPRINE | CLASSIFICATION | POOR-PROGNOSIS FACTORS | RHEUMATOLOGY 1990 CRITERIA | Recurrence | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Methotrexate - therapeutic use | Microscopic Polyangiitis - complications | Cyclophosphamide - therapeutic use | Microscopic Polyangiitis - mortality | Patient Selection | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - mortality | Churg-Strauss Syndrome - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Patient Safety | Adult | Female | Microscopic Polyangiitis - immunology | Peripheral Nervous System Diseases - complications | Peripheral Nervous System Diseases - immunology | Proteinuria - mortality | Peripheral Nervous System Diseases - mortality | Granulomatosis with Polyangiitis - mortality | Proteinuria - immunology | Treatment Outcome | Random Allocation | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Churg-Strauss Syndrome - complications | Proteinuria - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Churg-Strauss Syndrome - mortality | Adolescent | Survival Analysis | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Aged | Churg-Strauss Syndrome - immunology | Proteinuria - complications | Peripheral Nervous System Diseases - drug therapy | Antibodies, Antineutrophil Cytoplasmic - blood | Granulomatosis with Polyangiitis - complications | Complications and side effects | Cyclophosphamide | Vasculitis | Dosage and administration | Genetic aspects | Research | Methotrexate | Drug therapy | Nephrology | Transplants & implants | Hemodialysis | Toxicity | Granulomatosis | Arthritis | Peripheral neuropathy | Randomization | Antineutrophil cytoplasmic antibodies | Remission | Drug dosages | Kidneys | Internal medicine | Epidermal growth factor receptors | Leukocytes (eosinophilic) | Rheumatology | Maintenance | Patients | Medicine | Hospitals | Medical prognosis | Proteinuria | Kidney transplantation | Index Medicus
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2015, Volume 26, Issue 7, pp. 545 - 553
Journal Article
British Journal of Dermatology, ISSN 0007-0963, 06/2019, Volume 180, Issue 6, pp. e179 - e179
Journal Article
Clinical and experimental rheumatology, ISSN 0392-856X, 03/2018, Volume 36, Issue 2, pp. 78 - 84
Objective. Granulomatosis with polyangiitis is a rare autoimmune disease of the group of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides.... 
Granulomatosis with polyangiitis | Head | ENT | Otorhinolaryngology | Neck | Wegener’s granulomatosis | WEGENERS-GRANULOMATOSIS | INTERRATER RELIABILITY | PARANASAL SINUSES | CONSENSUS CONFERENCE | CLINICAL-ASSESSMENT | RHEUMATOLOGY | CHRONIC RHINOSINUSITIS | ENDONASAL ACTIVITY | granulomatosis with polyangiitis | NOMENCLATURE | EOSINOPHILIC GRANULOMATOSIS | head and neck | SYSTEMIC VASCULITIDES | Wegener's granulomatosis | otorhinolaryngology | Dysphonia - etiology | Granulomatosis with Polyangiitis - diagnostic imaging | Hearing Loss - etiology | Humans | Middle Aged | Rhinitis - etiology | Earache - etiology | Rhinitis - physiopathology | Epistaxis - physiopathology | Male | Earache - physiopathology | Young Adult | Tinnitus - etiology | Aged, 80 and over | Adult | Female | Granulomatosis with Polyangiitis - physiopathology | Otorhinolaryngologic Diseases - physiopathology | Otorhinolaryngologic Diseases - etiology | Hearing Tests | Tinnitus - physiopathology | Rhinomanometry | Otoscopy | Hearing Loss - physiopathology | Otorhinolaryngologic Diseases - diagnostic imaging | Laryngoscopy | Magnetic Resonance Imaging | Dizziness - etiology | Dizziness - physiopathology | Epistaxis - epidemiology | Olfaction Disorders - physiopathology | Adolescent | Dysphonia - physiopathology | Audiometry, Pure-Tone | Aged | Olfaction Disorders - etiology | Granulomatosis with Polyangiitis - complications
Journal Article
Journal Article
Rheumatology, ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 06/2015, Volume 74, Issue 6, pp. 1178 - 1182
Objectives The RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil... 
MAINTENANCE | Cyclophosphamide | Treatment | ANTIBODY-ASSOCIATED VASCULITIS | THERAPY | Granulomatosis with polyangiitis | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | B cells | RHEUMATOLOGY | Systemic vasculitis | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Renal Insufficiency, Chronic - etiology | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Microscopic Polyangiitis - complications | Cyclophosphamide - therapeutic use | Renal Insufficiency, Chronic - drug therapy | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - complications | Granulomatosis with Polyangiitis - immunology | Female | Microscopic Polyangiitis - immunology | Drug Therapy, Combination | B-Lymphocytes - cytology | Renal Insufficiency, Chronic - immunology | Rituximab | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Disease Progression | Disease-Free Survival | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - immunology | Lymphocyte Count | Microscopic Polyangiitis - drug therapy | Granulomatosis with Polyangiitis - drug therapy | Aged | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Granulomatosis with Polyangiitis - complications | Kidney Failure, Chronic - etiology | Usage | Care and treatment | Vasculitis | Patient outcomes | Clinical trials | Dosage and administration | Comparative analysis | Risk factors | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | B cells; Cyclophosphamide; Granulomatosis with polyangiitis; Systemic vasculitis; Treatment | Medicin och hälsovetenskap
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 11/2013, Volume 52, Issue 11, pp. 2041 - 2047
Objective. Rituximab (RTX) is an anti-CD20 antibody used successfully in granulomatosis with polyangiitis (GPA) for induction and maintenance of remission. Our... 
Hypogammaglobulinaemia | Infection | Granulomatosis with polyangiitis | Rituximab | Maintenance | Safety | ANCA-associated vasculitis | WEGENERS-GRANULOMATOSIS | infection | ANTIBODY-ASSOCIATED VASCULITIS | CYCLOPHOSPHAMIDE | MICROSCOPIC POLYANGIITIS | CONSENSUS CONFERENCE | FOLLOW-UP | INDUCTION | RHEUMATOLOGY | granulomatosis with polyangiitis | REFRACTORY GRANULOMATOSIS | safety | hypogammaglobulinaemia | maintenance | rituximab | REMISSION | Drug Evaluation - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Male | Young Adult | Granulomatosis with Polyangiitis - immunology | Adult | Female | Opportunistic Infections - immunology | Retrospective Studies | Immunosuppressive Agents - administration & dosage | Opportunistic Infections - complications | Drug Administration Schedule | Risk Factors | Treatment Outcome | CD4 Lymphocyte Count | Remission Induction | Adolescent | Granulomatosis with Polyangiitis - drug therapy | Immunosuppressive Agents - adverse effects | Aged | Immunocompromised Host | Antibodies, Monoclonal, Murine-Derived - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Granulomatosis with Polyangiitis - complications | Rheumatology: 759 | VDP | Reumatologi: 759 | Klinisk medisinske fag: 750 | Vaskulitt | Medisinske Fag: 700 | Clinical medical disciplines: 750 | Medical disciplines: 700
Journal Article
Journal Article